Galena Biopharma (SLS)
(Delayed Data from NSDQ)
$1.16 USD
-0.02 (-1.70%)
Updated Nov 6, 2024 04:00 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | NA |
EPS Last Quarter | -0.13 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
NA |
---|---|
Current Year | -0.55 |
Next Year | -0.42 |
EPS (TTM) | -0.92 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 1.00M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | -0.55 | -0.42 |
# of Estimates | NA | NA | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | NA | NA | -0.55 | -0.42 |
Low Estimate | NA | NA | -0.55 | -0.42 |
Year ago EPS | -0.33 | -0.25 | -1.34 | -0.55 |
Year over Year Growth Est. | NA | NA | 58.96% | 23.64% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | NA | NA | 0 | 0 |
Up Last 30 Days | NA | NA | 0 | 0 |
Up Last 60 Days | NA | NA | 0 | 0 |
Down Last 7 Days | NA | NA | 0 | 0 |
Down Last 30 Days | NA | NA | 0 | 0 |
Down Last 60 Days | NA | NA | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | NA | NA | -0.55 | -0.42 |
7 Days Ago | NA | NA | -0.55 | -0.42 |
30 Days Ago | NA | NA | -0.55 | -0.42 |
60 Days Ago | NA | NA | -0.55 | -0.42 |
90 Days Ago | NA | NA | -0.75 | -0.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | NA | NA | -0.55 | -0.42 |
Zacks Consensus Estimate | NA | NA | -0.55 | -0.42 |
Earnings ESP | NA | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.13 | -0.21 | -0.25 | -0.33 | NA |
Estimate | NA | NA | NA | NA | NA |
Difference | NA | NA | NA | NA | NA |
Surprise | NA | NA | NA | NA | NA |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more